Ariola Koci
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 4
-
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmaceutical industry and healthcare 1
- Inflammatory mediators and NSAID effects 1
- Co-authors
- Fabrizio De Ponti (15 shared papers)Elisabetta Poluzzi (15 shared papers)Emanuel Raschi (13 shared papers)Ugo Moretti (6 shared papers)Miriam Sturkenboom (5 shared papers)Paolo Caraceni (1 shared paper)Brian Godman (3 shared papers)Björn Wettermark (2 shared papers)
- Journals
- PLoS ONE (2 papers)Clinical Therapeutics (2 papers)Drug Safety (2 papers)European Journal of Clinical Pharmacology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- ItalyUnited KingdomNetherlands
In The Last Decade
Ariola Koci
16 papers receiving 398 citations
Peers
Comparison fields: 5 of 83
- Toxicology 58
- Pharmacology 56
- Internal Medicine 14
- Cardiology and Cardiovascular Medicine 88
- Gastroenterology 15
Countries citing papers authored by Ariola Koci
This map shows the geographic impact of Ariola Koci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariola Koci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariola Koci more than expected).
Fields of papers citing papers by Ariola Koci
This network shows the impact of papers produced by Ariola Koci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariola Koci. The network helps show where Ariola Koci may publish in the future.
Co-authors
The 25 scholars most cited alongside Ariola Koci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 65 | |
| 2 | 2013 | 60 | |
| 3 | 2014 | 57 | |
| 4 | 2015 | 55 | |
| 5 | 2013 | 46 | |
| 6 | 2016 | 30 | |
| 7 | 2015 | 20 | |
| 8 | 2016 | 19 | |
| 9 | 2017 | 14 | |
| 10 | 2012 | 12 | |
| 11 | 2017 | 9 | |
| 12 | 2014 | 6 | |
| 13 | 2015 | 5 | |
| 14 | 2015 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2015 | 1 |
About Ariola Koci
Ariola Koci is a scholar working on Toxicology, Pharmacology, Pharmacology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 16 papers that have together received 405 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Pharmaceutical industry and healthcare (1 paper), Pharmaceutical Economics and Policy (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Toxicology (58 citations), Pharmacology (56 citations), Internal Medicine (14 citations), Cardiology and Cardiovascular Medicine (88 citations) and Gastroenterology (15 citations). Ariola Koci has collaborated with scholars based in Italy, United Kingdom and Netherlands. Frequent co-authors include Fabrizio De Ponti, Elisabetta Poluzzi, Emanuel Raschi, Ugo Moretti, Miriam Sturkenboom, Paolo Caraceni, Brian Godman, Björn Wettermark, Marija Kalaba and Francesco Salvo. Their work appears in journals such as PLoS ONE, Clinical Therapeutics, Drug Safety, European Journal of Clinical Pharmacology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.